Literature DB >> 30586986

Disrupted iron metabolism in peritoneal fluid may induce oxidative stress in the peritoneal cavity of women with endometriosis.

Grzegorz Polak1, Bartłomiej Barczyński2, Iwona Wertel2, Wojciech Kwaśniewski2, Wiesława Bednarek2, Magdalena Derewianka-Polak3, Karolina Frąszczak2, Marcin Olajossy3, Jan Kotarski2.   

Abstract

INTRODUCTION: Data on the possible role of peritoneal fluid free radical-mediated oxidative damage in the pathogenesis of endometriosis still remains inconsistent. The aim of the study was to determine iron metabolism markers and their influence on oxidative stress arameters in the peritoneal fluid of women with endometriosis.
MATERIAL AND METHODS: 110 women with endometriosis and 119 patients with benign ovarian cysts were included in the study. All visible peritoneal fluid was aspirated during laparoscopy from the anterior and posterior cul-de-sacs. under direct vision to avoid blood contamination. Haemoglobin, iron, total oxidative status, and total antioxidant status were measured using standard colourimetric kits.
RESULTS: Haemoglobin, iron levels, as well as total oxidative status values were significantly higher, whereas total antioxidant status values were significantly lower in the peritoneal fluid of patients with endometriosis, in comparison to the reference groups. No differences were observed in peritoneal fluid concentrations of all parameters measured in relation to the phase of the menstrual cycle.
CONCLUSIONS: Peritoneal fluid of women with endometriosis is characterized by disrupted iron metabolism. This is most likely related to an increased number of erythrocytes in the peritoneal cavity of endometriotic women, which leads to a higher concentration of haemoglobin in this environment. Impaired iron homeostasis may have a significant influence on the pathophysiology of peritoneal endometriosis by the direct impact of haemoglobin derivatives and/or formation of the pro-inflammatory and pro-oxidative environment. Peritoneal cavity oxidative stress occurs predominantly in women in advanced stages of the disease.

Entities:  

Keywords:  Endometriosis; haemaglobin; iron; oxidative stress; peritoneal fluid; total antioxidant status; total oxidative status

Mesh:

Substances:

Year:  2017        PMID: 30586986     DOI: 10.26444/aaem/75802

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  6 in total

1.  The Impact of Controlled Ovarian Stimulation on Serum Oxidative Stress Markers in Infertile Women with Endometriosis Undergoing ICSI.

Authors:  Michele Gomes Da Broi; Elisa Melo Ferreira; Aline Zyman Andrade; Alceu Afonso Jordão; Rui Alberto Ferriani; Paula Andrea Navarro
Journal:  Antioxidants (Basel)       Date:  2022-06-14

2.  [Research progress on biomarkers for endometriosis based on lipidomics].

Authors:  Cuicui Lin; Zhengyun Chen; Chunyan Wang; Yongmei Xi
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-25

Review 3.  Iron Therapeutics in Women's Health: Past, Present, and Future.

Authors:  Joel Mintz; Jackie Mirza; Eric Young; Kyle Bauckman
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-08

4.  Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis.

Authors:  Haoxian Wang; Gang Zhou; Mingyan Zhuang; Wei Wang; Xianyun Fu
Journal:  PeerJ       Date:  2021-04-02       Impact factor: 2.984

Review 5.  Clinicopathological Characteristics and Outcomes of Patients With Endometriosis-Related Hemorrhagic Ascites: An Updated Systematic Review of the Literature.

Authors:  Anastasios Pandraklakis; Anastasia Prodromidou; Dimitrios Haidopoulos; Anna Paspala; Maria D Oikonomou; Nikolaos Machairiotis; Alexandros Rodolakis; Nikolaos Thomakos
Journal:  Cureus       Date:  2022-06-22

6.  Ferroptosis induced by iron overload promotes fibrosis in ovarian endometriosis and is related to subpopulations of endometrial stromal cells.

Authors:  Yanqin Zhang; Xinyu Liu; Mengqi Deng; Chunyu Xu; Yubo Zhang; Di Wu; Fan Tang; Ruiye Yang; Jinwei Miao
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.